Splicing variants of androgen receptor in prostate cancer

Significant advances in our understanding of continued androgen receptor (AR) signaling in castration-resistant prostate cancer have led to the development and FDA approval of two next-generation androgen-directed therapies, abiraterone and enzalutamide. These new therapies heralded a new era of pro...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Am J Clin Exp Urol
Главные авторы: Zhang, Haitao, Zhan, Yang, Liu, Xichun, Qi, Yanfeng, Zhang, Guanyi, Sartor, Oliver, Dong, Yan
Формат: Artigo
Язык:Inglês
Опубликовано: e-Century Publishing Corporation 2013
Предметы:
Review Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4219285/
https://ncbi.nlm.nih.gov/pubmed/25374896
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы